A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study)
-
Published:2024-08
Issue:
Volume:194
Page:107868
-
ISSN:0169-5002
-
Container-title:Lung Cancer
-
language:en
-
Short-container-title:Lung Cancer
Author:
Jacob MathildeORCID, Fournel Pierre, Tissot Claire, Cadranel Jacques, Bylicki OlivierORCID, Monnet Isabelle, Justeau Grégoire, Ricordel CharlesORCID, Thomas Pascal, Falchero LionelORCID, Locher Chrystel, Wislez Marie, Vergnenegre Alain, Abdiche Samir, Guisier Floran, Bizieux AcyaORCID, Lamy Regine, François Geraldine, De Chabot Gonzagues, Pierret ThomasORCID, Sabatini MarieORCID, Abeillera Marion, Vieillot Sabine, Martinez Stephanie, Morel HuguesORCID, Doubre Hélène, Madroszyk AnneORCID, Geier Margaux, LucLabourey Jean, Chouaïd Christos, Greillier Laurent
Reference70 articles.
1. Epidemiology of Stage III Lung Cancer: frequency, Diagnostic Characteristics, and Survival;Casal-Mouriño;Transl Lung Cancer Res.,2021 2. The 8th Lung Cancer TNM Classification and clinical Staging System: Review of the Changes andClinical Implications;Lim;Quant Imaging Med Surg.,2018 3. Early and locally Advanced Non-Small-Cell Lung Cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Postmus;AnnOncol.,2017281 4. Local treatment of Stage IIIA-N2 Non-Small Cell Lung Cancer: surgery and/or radiotherapy;Van Meerbeeck;CurrOpinOncol.,2020 5. International Guidelines on Stage III N2 Non-Small Cell Lung Cancer: surgery or radiotherapy?;Putora;ERJ Open Res.,2020
|
|